Jeremy Brower

Jeremy Brower currently serves as a Senior Scientist in Toxicology at Spark Therapeutics, Inc., a position held since October 2022. Prior to this role, Jeremy accumulated extensive experience at Lovelace Biomedical as an Associate Research Scientist from December 2012 to October 2022, and held the position of Preclinical Outsourcing Analyst at Reata Pharmaceuticals for a brief period in 2012. Earlier career highlights include serving as Director of Product Research at Stimwave Technologies, Inc., where Jeremy managed early research phases for a novel wireless neural stimulator, and as a Postdoctoral Research Assistant at the Mayo Clinic and Arizona State University, focusing on protein biomarker discovery and cancer research. Jeremy's academic background includes a PhD in Bioengineering from Arizona State University, complemented by research on glucose-induced endothelial damage and its implications for vascular disease and diabetes.